LYKALABSNSELyka Labs Limited· PharmaceuticalsMediumNeutral
Announced Tue, 31 Mar · 13:46 IST

Lyka Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on March 31, 2026.

Auditor Resigned MidtermManagement Changes View source PDF

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+21.9%1-day move
₹45.71
prior close
₹45.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.8+3.6+4.1+6.3+21.9+19.1+27.7+28.0+27.1+26.8+25.0+31.0+28.0+64.0
Up moveDown movePending
AI summary

Lyka Labs' board, at its meeting on March 31, 2026, approved the appointment of M/s. Nidhi Subhash Tibrewala & Co. (FRN 005417), Cost Accountants, as the new Cost Auditor. This appointment fills a casual vacancy caused by the resignation of the previous cost auditor, M/s. Rajaram M Walavalkar & Co., for the financial year 2025-26. The same firm has also been appointed as Cost Auditor for the financial year 2026-27. The new auditor is a Mumbai-based firm of practicing cost accountants. The board meeting ran from 12:00 pm to 1:35 pm.

Likely market impact

The change is administrative and routine — a cost auditor (not statutory auditor) was replaced mid-term and a new one appointed for the next year. No material impact expected on shareholders or the stock price.